321550 — TiumBio Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩188bn
- KR₩195bn
- KR₩5bn
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 88,883 | 68,576 | 40,635 | 18,130 | 34,409 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 703 | 957 | 1,102 | 19,535 | 8,550 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 90,438 | 69,851 | 41,901 | 40,295 | 45,311 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 859 | 2,682 | 14,826 | 24,362 | 42,031 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 93,457 | 85,351 | 116,735 | 96,259 | 119,546 |
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 958 | 1,777 | 4,467 | 30,110 | 11,666 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 958 | 2,845 | 29,162 | 35,221 | 49,468 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 92,498 | 82,507 | 87,573 | 61,038 | 70,078 |
Total Liabilities & Shareholders' Equity | 93,457 | 85,351 | 116,735 | 96,259 | 119,546 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |